Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
https://www.axios.com/2026/01/12/trump-fannie-mae-freddie-mac-congress...
https://www.axios.com/2026/01/12/most-expensive-zip-code...
The FSB has reported that it prevented an attempted terrorist attack on a railroad bridge in the Urals...
